IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells

Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B c...

Full description

Saved in:
Bibliographic Details
Published inLeukemia Vol. 25; no. 5; pp. 828 - 837
Main Authors Coscia, M, Pantaleoni, F, Riganti, C, Vitale, C, Rigoni, M, Peola, S, Castella, B, Foglietta, M, Griggio, V, Drandi, D, Ladetto, M, Bosia, A, Boccadoro, M, Massaia, M
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.05.2011
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0887-6924
1476-5551
1476-5551
DOI10.1038/leu.2011.12

Cover

Abstract Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.
AbstractList Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-κB (NF-κB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-κB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-κB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental pro-survival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Leukemia (2011) 25, 828-837; doi: 10.1038/leu.2011.12; published online 4 March 2011 Keywords: chronic lymphocytic leukemia; immunoglobulin mutational status; tumor microenvironment
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-κB (NF-κB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-κB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-κB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental pro-survival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Leukemia (2011) 25, 828-837; doi: 10.1038/leu.2011.12; published online 4 March 2011
Audience Academic
Author Vitale, C
Boccadoro, M
Drandi, D
Castella, B
Massaia, M
Riganti, C
Peola, S
Griggio, V
Rigoni, M
Ladetto, M
Pantaleoni, F
Foglietta, M
Coscia, M
Bosia, A
Author_xml – sequence: 1
  givenname: M
  surname: Coscia
  fullname: Coscia, M
  email: marta.coscia@unito.it
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 2
  givenname: F
  surname: Pantaleoni
  fullname: Pantaleoni, F
  organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 3
  givenname: C
  surname: Riganti
  fullname: Riganti, C
  organization: Dipartimento di Genetica, Biologia e Biochimica, Università di Torino
– sequence: 4
  givenname: C
  surname: Vitale
  fullname: Vitale, C
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 5
  givenname: M
  surname: Rigoni
  fullname: Rigoni, M
  organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 6
  givenname: S
  surname: Peola
  fullname: Peola, S
  organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 7
  givenname: B
  surname: Castella
  fullname: Castella, B
  organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 8
  givenname: M
  surname: Foglietta
  fullname: Foglietta, M
  organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 9
  givenname: V
  surname: Griggio
  fullname: Griggio, V
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 10
  givenname: D
  surname: Drandi
  fullname: Drandi, D
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 11
  givenname: M
  surname: Ladetto
  fullname: Ladetto, M
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 12
  givenname: A
  surname: Bosia
  fullname: Bosia, A
  organization: Dipartimento di Genetica, Biologia e Biochimica, Università di Torino
– sequence: 13
  givenname: M
  surname: Boccadoro
  fullname: Boccadoro, M
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
– sequence: 14
  givenname: M
  surname: Massaia
  fullname: Massaia, M
  organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24166145$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21372840$$D View this record in MEDLINE/PubMed
BookMark eNqFkk1v00AQhi1URNPCiTuyQMABHPbD--FjiaCtFIkLcLU2m3Gykb12veug_gd-NGMlEFqlqizZK8_zzsy-M2fJiW89JMlLSqaUcP2phmHKCKVTyp4kE5ormQkh6EkyIVqrTBYsP03OQtgQMgbls-SUUa6Yzskk-X19efUzHXwzRBNhmc7m8_RzaqGuQ2p6SJsWX12PFdPYpqFrfTQe2gGjXdvFNjg8-WUahsUGbBwh8FuHggYQrUdtGPqt2-I5uJU3mDiujU-PVHyePK0wDi_23_Pkx9cv32dX2fzb5fXsYp5ZoVTMGJHMMs5ASMOh0NyyXGmjgVOTcyaYlkaTgjFT2IpSUAvgwMDaxbKQii34efJxl3fwnbn9Zeq67HrXmP62pKQcTS3R1HI0taQM8fc7HO9yM0CIZePC2PDOiVKrnOq8oPJxUkomKBcEydf3yE079KM7CAlFKY4HoTcPQUzmAkfICT9QK1ND6XzVxt7YsXB5wTAVE5oqpKZHKHyW0DiL860c_r8jePefYA2mjuvQ1kN0rQ93wVf7LodFA8t_Vv5dMgTe7gETrKmr3njrwoHLqZQ0F8h92HEWdyb0UD0yFXqPtg43CrvDi7n6Ac1-8AEz-xX0B0OP4X8AiqwK7w
CODEN LEUKED
CitedBy_id crossref_primary_10_1002_ijc_28974
crossref_primary_10_1007_s00109_013_1081_6
crossref_primary_10_1038_leu_2012_44
crossref_primary_10_1016_j_blre_2016_10_001
crossref_primary_10_3390_cancers15194736
crossref_primary_10_3109_10428194_2011_610014
crossref_primary_10_1186_s12943_014_0286_9
crossref_primary_10_18632_oncotarget_8672
crossref_primary_10_2119_molmed_2011_00360
crossref_primary_10_1517_17530059_2012_637108
crossref_primary_10_1016_j_anndiagpath_2018_02_006
crossref_primary_10_1182_asheducation_2011_1_96
crossref_primary_10_1182_blood_2012_03_417519
crossref_primary_10_1182_blood_2012_08_452607
crossref_primary_10_3390_pharmaceutics16010055
crossref_primary_10_3390_cancers17010072
crossref_primary_10_3390_cancers14133087
crossref_primary_10_1007_s00262_012_1300_y
crossref_primary_10_1016_j_celrep_2019_10_106
crossref_primary_10_1038_s41598_021_82609_2
crossref_primary_10_1080_10408363_2019_1600468
crossref_primary_10_18632_oncotarget_4006
crossref_primary_10_3390_jcm12072731
crossref_primary_10_1371_journal_pone_0124936
crossref_primary_10_1007_s00277_013_1967_y
crossref_primary_10_1111_bjh_12580
crossref_primary_10_1371_journal_pone_0023758
crossref_primary_10_1007_s10637_011_9740_3
crossref_primary_10_1182_blood_2012_02_409110
crossref_primary_10_1080_10428194_2020_1811274
crossref_primary_10_1182_blood_2013_02_485540
crossref_primary_10_18632_oncotarget_3905
crossref_primary_10_1158_1078_0432_CCR_15_3099
crossref_primary_10_3389_frhem_2022_1004717
crossref_primary_10_1053_j_seminhematol_2014_05_002
crossref_primary_10_3390_cancers13122883
crossref_primary_10_1016_S0001_5814_12_70005_1
crossref_primary_10_1371_journal_pone_0109533
crossref_primary_10_1038_leu_2015_305
crossref_primary_10_1182_blood_2012_02_414060
crossref_primary_10_1182_blood_2012_08_447904
crossref_primary_10_3390_cancers12020524
crossref_primary_10_1038_leu_2014_188
crossref_primary_10_1016_j_exphem_2020_12_007
crossref_primary_10_1038_s41598_023_44039_0
crossref_primary_10_1016_j_drup_2019_100670
crossref_primary_10_1111_j_1365_2141_2012_09191_x
crossref_primary_10_1002_med_21341
crossref_primary_10_1016_j_hoc_2012_12_002
crossref_primary_10_3389_fonc_2020_01422
crossref_primary_10_3390_cells10020217
Cites_doi 10.2174/1568009043333032
10.1182/blood-2002-06-1822
10.1093/emboj/cdg004
10.1146/annurev.immunol.021908.132641
10.1172/JCI24176
10.1200/JCO.2008.19.1114
10.1056/NEJMra041720
10.4049/jimmunol.164.4.2200
10.1002/ijc.21832
10.1038/ni842
10.1182/blood-2009-06-225326
10.1182/blood-2007-06-094029
10.1097/CJI.0b013e318197b5e4
10.1074/jbc.M410994200
10.1111/j.1365-2567.2006.02377.x
10.1084/jem.177.4.925
10.1182/blood-2004-07-2669
10.1111/j.1365-2141.2008.07363.x
10.1182/blood-2005-08-3182
10.1182/blood.V99.3.1030
10.1093/emboj/cdf542
10.1158/1541-7786.MCR-08-0142
10.1046/j.1365-2141.1996.00305.x
10.1182/blood-2004-12-4918
10.1159/000087886
10.1126/science.1062677
10.1016/S0301-472X(02)01046-9
10.1111/j.1365-2796.2008.02030.x
10.1182/blood-2002-03-0746
10.1093/humrep/deh806
10.1182/blood-2009-07-233718
10.1200/JCO.2007.15.4393
10.1182/blood-2007-11-125278
10.1158/1078-0432.CCR-08-1673
10.1038/sj.leu.2404544
10.1182/blood.V99.5.1666
10.1111/j.1365-2567.2005.02117.x
10.1084/jem.176.5.1319
10.1182/blood-2004-03-0889
10.1016/j.it.2004.03.008
10.1182/blood.V96.8.2655
10.1182/blood.V94.6.1848
10.1182/blood.V87.10.4382.bloodjournal87104382
10.1182/blood.V94.6.1840
10.1182/blood.V91.7.2387
ContentType Journal Article
Copyright Macmillan Publishers Limited 2011
2015 INIST-CNRS
COPYRIGHT 2011 Nature Publishing Group
Macmillan Publishers Limited 2011.
Copyright Nature Publishing Group May 2011
Copyright_xml – notice: Macmillan Publishers Limited 2011
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2011 Nature Publishing Group
– notice: Macmillan Publishers Limited 2011.
– notice: Copyright Nature Publishing Group May 2011
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T5
7T7
7TM
7TO
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7N
M7P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
ADTOC
UNPAY
DOI 10.1038/leu.2011.12
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Nursing & Allied Health Database
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


AIDS and Cancer Research Abstracts
ProQuest Central Student
ProQuest Central Student
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
– sequence: 4
  dbid: BENPR
  name: ProQuest Central Database Suite (ProQuest)
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5551
EndPage 837
ExternalDocumentID 10.1038/leu.2011.12
2342897901
A257125817
21372840
24166145
10_1038_leu_2011_12
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
-Q-
.55
.XZ
0R~
29L
2WC
36B
39C
3V.
4.4
406
53G
5GY
5RE
70F
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AACDK
AANZL
AAQQT
AASDW
AASML
AATNV
AAWTL
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABJNI
ABLJU
ABOCM
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EBX
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
IHW
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
M7P
N9A
NADUK
NAO
NAPCQ
NQJWS
NXXTH
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
UKHRP
WOW
X7M
Y6R
ZGI
ZXP
~8M
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PUEGO
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
ACMFV
AEIIB
PMFND
7QL
7T5
7T7
7TM
7TO
7U9
7XB
8FD
8FE
8FH
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PKEHL
PQEST
PQUKI
PRINS
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c577t-2062c232e56a3e983c2478a8e31a4325286a80922a9cf11e7be3e2eccbd9672b3
IEDL.DBID UNPAY
ISSN 0887-6924
1476-5551
IngestDate Wed Oct 01 15:27:32 EDT 2025
Sun Sep 28 00:41:01 EDT 2025
Sun Sep 28 07:02:02 EDT 2025
Fri Jul 25 08:57:23 EDT 2025
Sat Aug 23 13:07:08 EDT 2025
Tue Jun 17 21:07:19 EDT 2025
Tue Jun 10 20:26:43 EDT 2025
Thu May 22 21:22:33 EDT 2025
Wed Feb 19 01:51:59 EST 2025
Mon Jul 21 09:17:19 EDT 2025
Wed Oct 01 03:37:31 EDT 2025
Thu Apr 24 23:09:44 EDT 2025
Fri Feb 21 02:37:57 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords chronic lymphocytic leukemia
immunoglobulin mutational status
tumor microenvironment
Human
Heavy peptide chain
Immunoglobulins
Hematology
Variable region
Spontaneous
Cell microenvironment
Malignant hemopathy
B-Lymphocyte
Signal transduction
Chronic lymphocytic leukemia
Cell death
Lymphoproliferative syndrome
Environment
Genetics
Mutation
Cancer
Apoptosis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c577t-2062c232e56a3e983c2478a8e31a4325286a80922a9cf11e7be3e2eccbd9672b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://proxy.k.utb.cz/login?url=https://www.nature.com/articles/leu201112.pdf
PMID 21372840
PQID 2645728303
PQPubID 30521
PageCount 10
ParticipantIDs unpaywall_primary_10_1038_leu_2011_12
proquest_miscellaneous_874184916
proquest_miscellaneous_866251350
proquest_journals_865711284
proquest_journals_2645728303
gale_infotracmisc_A257125817
gale_infotracacademiconefile_A257125817
gale_healthsolutions_A257125817
pubmed_primary_21372840
pascalfrancis_primary_24166145
crossref_primary_10_1038_leu_2011_12
crossref_citationtrail_10_1038_leu_2011_12
springer_journals_10_1038_leu_2011_12
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2011-05-01
PublicationDateYYYYMMDD 2011-05-01
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: Avenel, NJ
– name: England
PublicationTitle Leukemia
PublicationTitleAbbrev Leukemia
PublicationTitleAlternate Leukemia
PublicationYear 2011
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Hamblin, Davis, Gardiner, Oscier, Stevenson (CR3) 1999; 94
Damle, Wasil, Fais, Ghiotto, Valetto, Allen (CR2) 1999; 94
Kurtova, Balakrishnan, Chen, Ding, Schnabl, Quiroga (CR8) 2009; 114
Tsukada, Burger, Zvaifler, Kipps (CR11) 2002; 99
Burger, Ghia, Rosenwald, Caligaris-Cappio (CR12) 2009; 114
Rezvany, Jeddi-Tehrani, Wigzell, Osterborg, Mellstedt (CR37) 2003; 101
Caligaris-Cappio, Ghia (CR4) 2008; 26
Lanham, Hamblin, Oscier, Ibbotson, Stevenson, Packham (CR47) 2003; 101
Coope, Atkinson, Huhse, Belich, Janzen, Holman (CR29) 2002; 21
Packham, Stevenson (CR18) 2005; 114
Ghia, Chiorazzi, Stamatopoulos (CR1) 2008; 264
Ghia, Circosta, Scielzo, Vallario, Camporeale, Granziero (CR9) 2005; 294
Bojarska-Junak, Rolinski, Wasik-Szczepaneko, Kaluzny, Dmoszynska (CR42) 2002; 87
Petlickovski, Laurenti, Li, Marietti, Chiusolo, Sica (CR23) 2005; 105
Bonizzi, Karin (CR25) 2004; 25
Ricca, Rocci, Drandi, Francese, Compagno, Lobetti Bodoni (CR19) 2007; 21
Nishio, Endo, Tsukada, Ohata, Kitada, Reed (CR35) 2005; 106
Dancescu, Rubio-Trujillo, Biron, Bron, Delespesse, Sarfati (CR31) 1992; 176
Fahey, Schaefer, Channon, Wira (CR22) 2005; 20
Gorgun, Holderried, Zahrieh, Neuberg, Gribben (CR41) 2005; 115
Vallabhapurapu, Karin (CR26) 2009; 27
Mitsiades, Mitsiades, Koutsilieris (CR45) 2004; 4
Burger, Tsukada, Burger, Zvaifler, Dell’Aquila, Kipps (CR10) 2000; 96
Furman, Asgary, Mascarenhas, Liou, Schattner (CR17) 2000; 164
Francia di Celle, Mariani, Riera, Stacchini, Reato, Foa (CR44) 1996; 87
Hewamana, Lin, Jenkins, Burnett, Jordan, Fegan (CR48) 2008; 14
Deaglio, Vaisitti, Aydin, Bergui, D’Arena, Bonello (CR32) 2007; 110
de Oliveira Pinto, Garcia, Lecoeur, Rapp, Gougeon (CR20) 2002; 99
Chiorazzi, Rai, Ferrarini (CR38) 2005; 352
Ho, Hsu, Phyliky, Li (CR43) 2005; 114
Haiat, Billard, Quiney, Ajchenbaum-Cymbalista, Kolb (CR14) 2006; 118
Burger, Hartmann, Krome, Rawluk, Tamamura, Fujii (CR33) 2005; 106
Senftleben, Cao, Xiao, Greten, Krähn, Bonizzi (CR27) 2001; 293
Burger, Ghia, Rosenwald, Caligaris-Cappio (CR36) 2009; 114
Yilmaz, Weih, Sivakumar, Weih (CR28) 2003; 22
Ranheim, Kipps (CR13) 1993; 177
Hewamana, Alghazal, Lin, Clement, Jenkins, Guzman (CR24) 2008; 111
Tinhofer, Weiss, Gassner, Rubenzer, Holler, Greil (CR40) 2009; 32
Claudio, Brown, Park, Wang, Siebenlist (CR30) 2002; 3
Lagneaux, Delforge, Bron, De Bruyn, Stryckmans (CR5) 1998; 91
Röth, de Beer, Nückel, Sellmann, Dührsen, Dürig (CR39) 2008; 143
Hewamana, Lin, Rowntree, Karunanithi, Pratt, Hills (CR16) 2009; 27
Manna, Ramesh (CR46) 2005; 280
Burger, Kipps (CR7) 2006; 107
Zaninoni, Imperiali, Pasquini, Zanella, Barcellini (CR15) 2003; 31
Hegde, Peterson, Emanuel, Mittal, Joshi, Dickinson (CR34) 2008; 6
Panayiotidis, Jones, Ganeshaguru, Foroni, Hoffbrand (CR6) 1996; 92
Riganti, Orecchia, Pescarmona, Betta, Ghigo, Bosia (CR21) 2006; 119
N Tsukada (BFleu201112_CR11) 2002; 99
G Gorgun (BFleu201112_CR41) 2005; 115
S Haiat (BFleu201112_CR14) 2006; 118
S Hewamana (BFleu201112_CR48) 2008; 14
EA Ranheim (BFleu201112_CR13) 1993; 177
S Hewamana (BFleu201112_CR24) 2008; 111
AV Kurtova (BFleu201112_CR8) 2009; 114
LM de Oliveira Pinto (BFleu201112_CR20) 2002; 99
JA Burger (BFleu201112_CR10) 2000; 96
GV Hegde (BFleu201112_CR34) 2008; 6
HJ Coope (BFleu201112_CR29) 2002; 21
A Bojarska-Junak (BFleu201112_CR42) 2002; 87
JA Burger (BFleu201112_CR12) 2009; 114
S Vallabhapurapu (BFleu201112_CR26) 2009; 27
E Claudio (BFleu201112_CR30) 2002; 3
M Burger (BFleu201112_CR33) 2005; 106
A Röth (BFleu201112_CR39) 2008; 143
JV Fahey (BFleu201112_CR22) 2005; 20
I Tinhofer (BFleu201112_CR40) 2009; 32
M Nishio (BFleu201112_CR35) 2005; 106
P Francia di Celle (BFleu201112_CR44) 1996; 87
TJ Hamblin (BFleu201112_CR3) 1999; 94
A Petlickovski (BFleu201112_CR23) 2005; 105
ZB Yilmaz (BFleu201112_CR28) 2003; 22
JA Burger (BFleu201112_CR36) 2009; 114
G Bonizzi (BFleu201112_CR25) 2004; 25
P Ghia (BFleu201112_CR9) 2005; 294
C Riganti (BFleu201112_CR21) 2006; 119
N Chiorazzi (BFleu201112_CR38) 2005; 352
I Ricca (BFleu201112_CR19) 2007; 21
U Senftleben (BFleu201112_CR27) 2001; 293
G Packham (BFleu201112_CR18) 2005; 114
CS Mitsiades (BFleu201112_CR45) 2004; 4
P Panayiotidis (BFleu201112_CR6) 1996; 92
S Deaglio (BFleu201112_CR32) 2007; 110
MR Rezvany (BFleu201112_CR37) 2003; 101
S Hewamana (BFleu201112_CR16) 2009; 27
F Caligaris-Cappio (BFleu201112_CR4) 2008; 26
P Ghia (BFleu201112_CR1) 2008; 264
JA Burger (BFleu201112_CR7) 2006; 107
S Lanham (BFleu201112_CR47) 2003; 101
L Lagneaux (BFleu201112_CR5) 1998; 91
RN Damle (BFleu201112_CR2) 1999; 94
CL Ho (BFleu201112_CR43) 2005; 114
SK Manna (BFleu201112_CR46) 2005; 280
A Zaninoni (BFleu201112_CR15) 2003; 31
M Dancescu (BFleu201112_CR31) 1992; 176
RR Furman (BFleu201112_CR17) 2000; 164
References_xml – volume: 4
  start-page: 235
  year: 2004
  end-page: 256
  ident: CR45
  article-title: The Akt pathway: molecular targets for anti-cancer drug development
  publication-title: Curr Cancer Drug Targets
  doi: 10.2174/1568009043333032
– volume: 101
  start-page: 1087
  year: 2003
  end-page: 1093
  ident: CR47
  article-title: Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2002-06-1822
– volume: 22
  start-page: 121
  year: 2003
  end-page: 130
  ident: CR28
  article-title: RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF
  publication-title: EMBO J
  doi: 10.1093/emboj/cdg004
– volume: 27
  start-page: 693
  year: 2009
  end-page: 733
  ident: CR26
  article-title: Regulation and function of NF-kappaB transcription factors in the immune system
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.021908.132641
– volume: 115
  start-page: 1797
  year: 2005
  end-page: 1805
  ident: CR41
  article-title: Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8T cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI24176
– volume: 27
  start-page: 763
  year: 2009
  end-page: 769
  ident: CR16
  article-title: Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.19.1114
– volume: 352
  start-page: 804
  year: 2005
  end-page: 815
  ident: CR38
  article-title: Chronic lymphocytic leukemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra041720
– volume: 164
  start-page: 2200
  year: 2000
  end-page: 2206
  ident: CR17
  article-title: Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.4.2200
– volume: 119
  start-page: 17
  year: 2006
  end-page: 27
  ident: CR21
  article-title: Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21832
– volume: 3
  start-page: 958
  year: 2002
  end-page: 965
  ident: CR30
  article-title: BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells
  publication-title: Nat Immunol
  doi: 10.1038/ni842
– volume: 114
  start-page: 3367
  year: 2009
  end-page: 3375
  ident: CR12
  article-title: The microenvironment in mature B-cell malignancies: a target for new treatment strategies
  publication-title: Blood
  doi: 10.1182/blood-2009-06-225326
– volume: 110
  start-page: 4012
  year: 2007
  end-page: 4021
  ident: CR32
  article-title: CD38 and ZAP-70 are functionally linked and mark CLL B cells with high migratory potential
  publication-title: Blood
  doi: 10.1182/blood-2007-06-094029
– volume: 32
  start-page: 302
  year: 2009
  end-page: 309
  ident: CR40
  article-title: Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease
  publication-title: J Immunother
  doi: 10.1097/CJI.0b013e318197b5e4
– volume: 280
  start-page: 7010
  year: 2005
  end-page: 7021
  ident: CR46
  article-title: Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M410994200
– volume: 118
  start-page: 281
  year: 2006
  end-page: 292
  ident: CR14
  article-title: Role of BAFF and APRIL in human B-cell chronic lymphocytic leukemia
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2006.02377.x
– volume: 177
  start-page: 925
  year: 1993
  end-page: 935
  ident: CR13
  article-title: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal
  publication-title: J Exp Med
  doi: 10.1084/jem.177.4.925
– volume: 105
  start-page: 4820
  year: 2005
  end-page: 4827
  ident: CR23
  article-title: Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2669
– volume: 114
  start-page: 3367
  year: 2009
  end-page: 3375
  ident: CR36
  article-title: The microenvironment in mature B-cell malignancies: a target for new treatment strategies
  publication-title: Blood
  doi: 10.1182/blood-2009-06-225326
– volume: 143
  start-page: 383
  year: 2008
  end-page: 386
  ident: CR39
  article-title: Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukemia
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2008.07363.x
– volume: 107
  start-page: 1761
  year: 2006
  end-page: 1767
  ident: CR7
  article-title: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
  publication-title: Blood
  doi: 10.1182/blood-2005-08-3182
– volume: 99
  start-page: 1030
  year: 2002
  end-page: 1037
  ident: CR11
  article-title: Distinctive features of ‘nurselike’ cells that differentiate in the context of chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood.V99.3.1030
– volume: 21
  start-page: 5375
  year: 2002
  end-page: 5385
  ident: CR29
  article-title: CD40 regulates the processing of NF-κB2 p100 to p 52
  publication-title: EMBO J
  doi: 10.1093/emboj/cdf542
– volume: 6
  start-page: 1928
  year: 2008
  end-page: 1936
  ident: CR34
  article-title: Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-08-0142
– volume: 92
  start-page: 97
  year: 1996
  end-page: 103
  ident: CR6
  article-title: Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukemia cells
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1996.00305.x
– volume: 106
  start-page: 1824
  year: 2005
  end-page: 1830
  ident: CR33
  article-title: Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
  publication-title: Blood
  doi: 10.1182/blood-2004-12-4918
– volume: 114
  start-page: 133
  year: 2005
  end-page: 140
  ident: CR43
  article-title: Autocrine expression of platelet-derived growth factor B in B cell chronic lymphocytic leukemia
  publication-title: Acta Haematol
  doi: 10.1159/000087886
– volume: 94
  start-page: 1840
  year: 1999
  end-page: 1847
  ident: CR2
  article-title: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
  publication-title: Blood
– volume: 91
  start-page: 2387
  year: 1998
  end-page: 2396
  ident: CR5
  article-title: Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells
  publication-title: Blood
– volume: 293
  start-page: 1495
  year: 2001
  end-page: 1499
  ident: CR27
  article-title: Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway
  publication-title: Science
  doi: 10.1126/science.1062677
– volume: 294
  start-page: 135
  year: 2005
  end-page: 145
  ident: CR9
  article-title: Differential effects on CLL cell survival exerted by different microenvironmental elements
  publication-title: Curr Top Microbiol Immunol
– volume: 31
  start-page: 185
  year: 2003
  end-page: 190
  ident: CR15
  article-title: Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia
  publication-title: Exp Hematol
  doi: 10.1016/S0301-472X(02)01046-9
– volume: 264
  start-page: 549
  year: 2008
  end-page: 562
  ident: CR1
  article-title: Microenvironmental influences in chronic lymphocytic leukemia: the role of antigen stimulation
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2008.02030.x
– volume: 101
  start-page: 1063
  year: 2003
  end-page: 1070
  ident: CR37
  article-title: Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia
  publication-title: Blood
  doi: 10.1182/blood-2002-03-0746
– volume: 20
  start-page: 1439
  year: 2005
  end-page: 1446
  ident: CR22
  article-title: Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deh806
– volume: 114
  start-page: 4441
  year: 2009
  end-page: 4450
  ident: CR8
  article-title: Diverse marrow stromal cells protect CLL B cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance
  publication-title: Blood
  doi: 10.1182/blood-2009-07-233718
– volume: 96
  start-page: 2655
  year: 2000
  end-page: 2663
  ident: CR10
  article-title: Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1
  publication-title: Blood
– volume: 26
  start-page: 4497
  year: 2008
  end-page: 4503
  ident: CR4
  article-title: Novel insights in chronic lymphocytic leukemia: are we coming closer to understanding the pathogenesis of the disease?
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.15.4393
– volume: 111
  start-page: 4681
  year: 2008
  end-page: 4689
  ident: CR24
  article-title: The NF-kappaB subunit Rel A is associated with survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target
  publication-title: Blood
  doi: 10.1182/blood-2007-11-125278
– volume: 87
  start-page: 490
  year: 2002
  end-page: 499
  ident: CR42
  article-title: Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia
  publication-title: Haematologica
– volume: 14
  start-page: 8102
  year: 2008
  end-page: 8111
  ident: CR48
  article-title: The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-1673
– volume: 94
  start-page: 1848
  year: 1999
  end-page: 1854
  ident: CR3
  article-title: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
  publication-title: Blood
– volume: 21
  start-page: 697
  year: 2007
  end-page: 705
  ident: CR19
  article-title: Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404544
– volume: 99
  start-page: 1666
  year: 2002
  end-page: 1675
  ident: CR20
  article-title: Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3
  publication-title: Blood
  doi: 10.1182/blood.V99.5.1666
– volume: 114
  start-page: 441
  year: 2005
  end-page: 449
  ident: CR18
  article-title: Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukemia
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2005.02117.x
– volume: 176
  start-page: 1319
  year: 1992
  end-page: 1326
  ident: CR31
  article-title: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression
  publication-title: J Exp Med
  doi: 10.1084/jem.176.5.1319
– volume: 106
  start-page: 1012
  year: 2005
  end-page: 1020
  ident: CR35
  article-title: Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0889
– volume: 25
  start-page: 280
  year: 2004
  end-page: 288
  ident: CR25
  article-title: The two NF-κB activation pathways and their role in innate and adaptive immunity
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.03.008
– volume: 87
  start-page: 4382
  year: 1996
  end-page: 4389
  ident: CR44
  article-title: Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion
  publication-title: Blood
– volume: 32
  start-page: 302
  year: 2009
  ident: BFleu201112_CR40
  publication-title: J Immunother
  doi: 10.1097/CJI.0b013e318197b5e4
– volume: 114
  start-page: 3367
  year: 2009
  ident: BFleu201112_CR12
  publication-title: Blood
  doi: 10.1182/blood-2009-06-225326
– volume: 280
  start-page: 7010
  year: 2005
  ident: BFleu201112_CR46
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M410994200
– volume: 114
  start-page: 133
  year: 2005
  ident: BFleu201112_CR43
  publication-title: Acta Haematol
  doi: 10.1159/000087886
– volume: 6
  start-page: 1928
  year: 2008
  ident: BFleu201112_CR34
  publication-title: Mol Cancer Res
  doi: 10.1158/1541-7786.MCR-08-0142
– volume: 87
  start-page: 490
  year: 2002
  ident: BFleu201112_CR42
  publication-title: Haematologica
– volume: 96
  start-page: 2655
  year: 2000
  ident: BFleu201112_CR10
  publication-title: Blood
  doi: 10.1182/blood.V96.8.2655
– volume: 27
  start-page: 693
  year: 2009
  ident: BFleu201112_CR26
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.021908.132641
– volume: 99
  start-page: 1030
  year: 2002
  ident: BFleu201112_CR11
  publication-title: Blood
  doi: 10.1182/blood.V99.3.1030
– volume: 22
  start-page: 121
  year: 2003
  ident: BFleu201112_CR28
  publication-title: EMBO J
  doi: 10.1093/emboj/cdg004
– volume: 20
  start-page: 1439
  year: 2005
  ident: BFleu201112_CR22
  publication-title: Hum Reprod
  doi: 10.1093/humrep/deh806
– volume: 294
  start-page: 135
  year: 2005
  ident: BFleu201112_CR9
  publication-title: Curr Top Microbiol Immunol
– volume: 115
  start-page: 1797
  year: 2005
  ident: BFleu201112_CR41
  publication-title: J Clin Invest
  doi: 10.1172/JCI24176
– volume: 25
  start-page: 280
  year: 2004
  ident: BFleu201112_CR25
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2004.03.008
– volume: 143
  start-page: 383
  year: 2008
  ident: BFleu201112_CR39
  publication-title: Br J Haematol
  doi: 10.1111/j.1365-2141.2008.07363.x
– volume: 111
  start-page: 4681
  year: 2008
  ident: BFleu201112_CR24
  publication-title: Blood
  doi: 10.1182/blood-2007-11-125278
– volume: 94
  start-page: 1848
  year: 1999
  ident: BFleu201112_CR3
  publication-title: Blood
  doi: 10.1182/blood.V94.6.1848
– volume: 114
  start-page: 441
  year: 2005
  ident: BFleu201112_CR18
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2005.02117.x
– volume: 177
  start-page: 925
  year: 1993
  ident: BFleu201112_CR13
  publication-title: J Exp Med
  doi: 10.1084/jem.177.4.925
– volume: 21
  start-page: 697
  year: 2007
  ident: BFleu201112_CR19
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404544
– volume: 110
  start-page: 4012
  year: 2007
  ident: BFleu201112_CR32
  publication-title: Blood
  doi: 10.1182/blood-2007-06-094029
– volume: 264
  start-page: 549
  year: 2008
  ident: BFleu201112_CR1
  publication-title: J Intern Med
  doi: 10.1111/j.1365-2796.2008.02030.x
– volume: 107
  start-page: 1761
  year: 2006
  ident: BFleu201112_CR7
  publication-title: Blood
  doi: 10.1182/blood-2005-08-3182
– volume: 176
  start-page: 1319
  year: 1992
  ident: BFleu201112_CR31
  publication-title: J Exp Med
  doi: 10.1084/jem.176.5.1319
– volume: 92
  start-page: 97
  year: 1996
  ident: BFleu201112_CR6
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1996.00305.x
– volume: 87
  start-page: 4382
  year: 1996
  ident: BFleu201112_CR44
  publication-title: Blood
  doi: 10.1182/blood.V87.10.4382.bloodjournal87104382
– volume: 94
  start-page: 1840
  year: 1999
  ident: BFleu201112_CR2
  publication-title: Blood
  doi: 10.1182/blood.V94.6.1840
– volume: 27
  start-page: 763
  year: 2009
  ident: BFleu201112_CR16
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2008.19.1114
– volume: 101
  start-page: 1087
  year: 2003
  ident: BFleu201112_CR47
  publication-title: Blood
  doi: 10.1182/blood-2002-06-1822
– volume: 31
  start-page: 185
  year: 2003
  ident: BFleu201112_CR15
  publication-title: Exp Hematol
  doi: 10.1016/S0301-472X(02)01046-9
– volume: 164
  start-page: 2200
  year: 2000
  ident: BFleu201112_CR17
  publication-title: J Immunol
  doi: 10.4049/jimmunol.164.4.2200
– volume: 99
  start-page: 1666
  year: 2002
  ident: BFleu201112_CR20
  publication-title: Blood
  doi: 10.1182/blood.V99.5.1666
– volume: 119
  start-page: 17
  year: 2006
  ident: BFleu201112_CR21
  publication-title: Int J Cancer
  doi: 10.1002/ijc.21832
– volume: 21
  start-page: 5375
  year: 2002
  ident: BFleu201112_CR29
  publication-title: EMBO J
  doi: 10.1093/emboj/cdf542
– volume: 106
  start-page: 1824
  year: 2005
  ident: BFleu201112_CR33
  publication-title: Blood
  doi: 10.1182/blood-2004-12-4918
– volume: 106
  start-page: 1012
  year: 2005
  ident: BFleu201112_CR35
  publication-title: Blood
  doi: 10.1182/blood-2004-03-0889
– volume: 114
  start-page: 4441
  year: 2009
  ident: BFleu201112_CR8
  publication-title: Blood
  doi: 10.1182/blood-2009-07-233718
– volume: 3
  start-page: 958
  year: 2002
  ident: BFleu201112_CR30
  publication-title: Nat Immunol
  doi: 10.1038/ni842
– volume: 293
  start-page: 1495
  year: 2001
  ident: BFleu201112_CR27
  publication-title: Science
  doi: 10.1126/science.1062677
– volume: 114
  start-page: 3367
  year: 2009
  ident: BFleu201112_CR36
  publication-title: Blood
  doi: 10.1182/blood-2009-06-225326
– volume: 91
  start-page: 2387
  year: 1998
  ident: BFleu201112_CR5
  publication-title: Blood
  doi: 10.1182/blood.V91.7.2387
– volume: 4
  start-page: 235
  year: 2004
  ident: BFleu201112_CR45
  publication-title: Curr Cancer Drug Targets
  doi: 10.2174/1568009043333032
– volume: 26
  start-page: 4497
  year: 2008
  ident: BFleu201112_CR4
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.15.4393
– volume: 14
  start-page: 8102
  year: 2008
  ident: BFleu201112_CR48
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-08-1673
– volume: 352
  start-page: 804
  year: 2005
  ident: BFleu201112_CR38
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra041720
– volume: 101
  start-page: 1063
  year: 2003
  ident: BFleu201112_CR37
  publication-title: Blood
  doi: 10.1182/blood-2002-03-0746
– volume: 105
  start-page: 4820
  year: 2005
  ident: BFleu201112_CR23
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2669
– volume: 118
  start-page: 281
  year: 2006
  ident: BFleu201112_CR14
  publication-title: Immunology
  doi: 10.1111/j.1365-2567.2006.02377.x
SSID ssj0014766
Score 2.2683108
Snippet Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo...
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo...
SourceID unpaywall
proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 828
SubjectTerms 631/208/737
631/80/82/23
692/699/67/1990/283/1895
Adult
Aged
Aged, 80 and over
Apoptosis
B cells
B-cell receptor
B-Lymphocytes - metabolism
B-Lymphocytes - pathology
Bcl-2 protein
Biological and medical sciences
Blotting, Western
Bone marrow
Cancer Research
CD40 antigen
CD40 Ligand - metabolism
Chronic lymphocytic leukemia
Critical Care Medicine
Cytokines
Development and progression
Electrophoretic Mobility Shift Assay
Female
Genetic aspects
Health aspects
Hematologic and hematopoietic diseases
Hematology
Humans
Immunoglobulin Heavy Chains - genetics
Immunoglobulin Variable Region - genetics
Immunoglobulins
In vivo methods and tests
Intensive
Interleukin 4
Internal Medicine
Laboratories
Leukemia
Leukemia, Lymphocytic, Chronic, B-Cell - genetics
Leukemia, Lymphocytic, Chronic, B-Cell - immunology
Leukemia, Lymphocytic, Chronic, B-Cell - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Leukocytes (mononuclear)
Ligands
Lymphatic leukemia
Lymphocytes
Lymphocytes B
Lymphocytes T
Lymphoma
Male
Medical sciences
Medicine
Medicine & Public Health
Middle Aged
Mutation - genetics
NF-kappa B - genetics
NF-kappa B - metabolism
NF-κB protein
Oncology
original-article
Peripheral blood mononuclear cells
Physiological aspects
Proto-Oncogene Proteins c-bcl-2 - metabolism
Receptors, Antigen, B-Cell - metabolism
Signal Transduction
Stromal cells
Therapeutic applications
Tumor cells
Tumor Cells, Cultured
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEA56gp6I-Nt655mHOwShXNO0Sfok5-G5yumTJ_tW0iQFYW171xbxf_CPdqbNdndx2beFTHbS5JvJl2QyIeRYlrosYGIORWSjMBHMhoUVmIuQFTxxpSrHaItvYnaVfJmnc7_h1vqwyqVPHBy1rQ3ukZ_CxJ1KzFbF3zfXIb4ahaer_gmN2-QOA6qCqJbzacHFEjmeVaIhCVho-Pt5EVenC9eP-TtZvDEjeb_8oNEt9FE5Pm6xjX2unZzeJ_f6qtF_fuvFYm1yunhEHnpWSc9GGDwmt1z1hNz96s_Nn5K_nz_NftC--tUjt7T0_PKSfqC4ad9SfeMoRttSUF452tUUo2aBM7q6h9Kmbrq6_Qm_KkvbvsB9GxRauyEHmqFu24PXAdxSDAkBUFPclKdbND4jVxcfv5_PQv8OQ2hSKTswJBEbYF4uFZq7THETJ1Jp5TjTCY_TWAmtoiyOdWZKxpwsHHcxYKOwmZBxwZ-TvQq-4CWhWSmVMVmEV4wSm8FEIS23mC40cgqoYEDeLcciNz5JOb6VsciHw3Kuchi4HAcuZyB8PAk3Y26O7WJvcFDz8WLpZNH5GXgroHeKyYC8HSTQpkGb0f5qArQZs2NtSB5uSIItmo3iow3gTM0CnoREKIX6SyTl3lm0-QraATn4v1gJ-HukEQGhUykqxvC4AQsgAstYxtNohwimKUpgMRCQFyOCV41jHNQnUPlkCemV9q0dejLhfVfHv9r9sQdkf9ygx-jRQ7LX3fTuNTC8rjgazPgfaBpNXg
  priority: 102
  providerName: ProQuest
Title IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
URI https://link.springer.com/article/10.1038/leu.2011.12
https://www.ncbi.nlm.nih.gov/pubmed/21372840
https://www.proquest.com/docview/2645728303
https://www.proquest.com/docview/865711284
https://www.proquest.com/docview/866251350
https://www.proquest.com/docview/874184916
https://www.nature.com/articles/leu201112.pdf
UnpaywallVersion publishedVersion
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1476-5551
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: KQ8
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVEBS
  databaseName: Academic Search Ultimate - eBooks
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1476-5551
  dateEnd: 20151130
  omitProxy: true
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: ABDBF
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1476-5551
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1476-5551
  dateEnd: 20241004
  omitProxy: true
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: 7X7
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central Database Suite (ProQuest)
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1476-5551
  dateEnd: 20241004
  omitProxy: true
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: BENPR
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1476-5551
  dateEnd: 20171231
  omitProxy: true
  ssIdentifier: ssj0014766
  issn: 1476-5551
  databaseCode: 8C1
  dateStart: 19970201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdrAvtg7Psja5fpoWUwcGdZtiQ_pqFdNrpQxjKyJyPbMpRmTqhtxvY37I_eXSSnyRZKX0JAp5x0uTv9JN2dCNmXhS5SWJg94ee-FwqWe2kusBYhS3loClXYaIuxGE3CT9No6pLVKxdWaUtaLt10Gx32fmYaXKoYbAPzYod0Bd4ndUh3Mj4bfG-reYrYPmIbSuFFAAVcPp7PFfa39TpZsLECOT98f6ErkElhH7PYhjbXbkrvkTtNudC_furZbG0xOnlIxu00bAzKxWFTp4fZ738qPN54no_IAwdL6cASPCa3TPmE3P7sLt6fkj8fP4y-0ab80SA4zenw9JQeUTz1r6i-NBTDdSkMpzS0nlMMuwXQaeYNtC7mi3pencO3MqdVk-LBDxKtpdgBZ-hbNeC2QPEpxpSAVVA81adbOD4jk5Pjr8OR5x5y8LJIyhosUQQZQDcTCc1NrHgWhFJpZTjTIQ-iQAmt_DgIdJwVjBmZGm4CUK40j4UMUv6cdEqYwUtC40KqLIt9zFEK8xhWGpnzHOuN-kYBluyRd-2fm2Suyjk-tjFLlrftXCUg4QRFnDAg3l8RL2xxj-1kb1BLEpuZunIJyQDcHeBDxWSPvF1SoFMAbpl2uQ0wZiyvtUG5t0EJxpxtNPc3NHE1LABaiKQi6N-qZuK8TZUAqI0kVnLjPbL7f7MS8POIQ3qErlqRMcbXLXUBSGAfzHjkX0OCdY5C2E30yAtrEleDYxzYh9D5oLWRK-5bBXqwMqDrBP_qhnS75K496sc41D3SqS8b8xqwYp32yY6cSvhUQ9Yn3aPj8dmXvvMafwGYK2p2
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDYiCEuI6ysflhFRJStPiS2HlAaAxGy7o9bahvmZM4ElKXhKXRtH_gW_hGzmkubUXVt71F8nGOnXN1zsWEHKjUpBEYZsd3E9eRPkucKPGxFyGLhLSpTutsi3N_cCl_jL3xBvnb1sJgWmWrE2eKOslj_Ed-CIbbU9itSnwufjt4axRGV9srNGq2OLV3t3BkKz8NvwJ9-5yffLs4HjjNrQJO7Ck1BbbweQx-hPV8I2ygRcyl0kZbwYwU3OPaN9oNODdBnDJmVWSF5bDTKAl8xSMB731AHkrhSuzVr8bdAY9JVcdGUXB9ONg09YCu0IcTW9X9QhlfsoCNHXhamBJoktaXaazydhcitU_IVpUV5u7WTCYLxvDkOXnWeLH0qGa7F2TDZi_Jo7MmTv-K_Bl-H_ykVXZdoS-b0OPRiH6hGCQoqbmxFLN7KSDPLJ3mFLN0wUe1eQWjRV5M8_IXPGUJLasI_xMh0EJFHmCGuWUFWg7khGIKCggRxSAAXYHxNbm8Fwq9IZsZ7OAtoUGqdBwHLpY0ySQAw6QSkWB7UtdqcD175GNLizBumqLj3RyTcBacFzoEwoVIuJAB8EEHXNS9QFaD7SNRw7qQtdMg4RFoR3AnNVM98mEGgToEsMWmKYWANWM3riXI3SVIkP14aXhviXG6ZYFfho6XB_NbTgob5VSGc1HqkZ3_h7UPr0e3pUdoN4qIMR1vxgsAAsdmJjx3DQi2RZJw-OiR7ZqD54tjAtBLmNxvWXqOfeUH7Xf8vu7Dv1u_2X2yNbg4G4Wj4fnpDnlcBwcwc3WXbE5vKvsevMtptDcTaUqu7luH_ANFfYk-
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BpDGiCE-BxlY_PDKiSkqLGdxM4DQmOjtKxMPDDUt8xJHAmpS8OSaNp_4Bfx67jLV1tR9W1vkXzO2bnzfeQ-TMiRTHQSgmK2PDu2LcdjsRXGHvYiZKFwTKKSOtvi3BtdOF-n7nSL_G1rYTCtspWJlaCO5xH-Ix-A4nYldqsSg6RJi_h-OvyY_bbwBimMtLbXadQscmZub8B9yz-MT4HWfc6Hn3-cjKzmhgErcqUsgEU8HoFNYVxPC-MrEXFHKq2MYNoR3OXK08r2Odd-lDBmZGiE4bDrMPY9yUMB771H7kvhCEwnk9PO2WOOrOOkeIg9cHKa2kBbqMHMlHXvUMZXtGGjEx5nOgf6JPXFGuss36Wo7SPyoEwzfXujZ7MlxTh8Sp40Fi09rlnwGdky6XOy862J2b8gf8ZfRj9pmV6VaNfG9GQyoZ8oBgxyqq8NxUxfCshTQ4s5xYxdsFfNvITRbJ4V8_wXPKUxzcsQ_xkh0FJ1HmCGuXkJEg_ODMV0FDhQFAMCdA3Gl-TiTij0imynsIPXhPqJVFHk21je5MQ-KCkZixhbldpGgRnaI-9bWgRR0yAd7-mYBVWgXqgACBcg4QIGwEcdcFb3BVkPdohEDeqi1k6aBMcgKcG0VEz2yLsKAuUJYIt0UxYBa8bOXCuQ-yuQIAeileGDFcbplgU2GhphLsxvOSloBFUeLI5Vj-z9P6w8eD2aMD1Cu1FEjKl5FS8ACLjQTLj2BhBskeSAI9IjuzUHLxbHBKB3YHK_ZekF9rUftN_x-6YP_2bzZg_JDkiPYDI-P9sjD-s4ASax7pPt4ro0b8HQLMKD6kRTcnnXIuQf_0WNeQ
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegk2AI8f0RNoYfNiFNyojjxHYey8QoaFQ8UDSeIidxJLSSVksiBH8DfzR3tZM1UE17q-Rzz77cnX-2786E7MtSlxkszL4IisCPBCv8rBBYi5BlPDKlKm20xVRMZtHHs_jMJavXLqzSlrRcuekuOuzN3LS4VDHYBhblTbIl8D5pRLZm08_jb101T5HYR2wjKfwYoIDLxwu4wv62XicLByuQ88N3l7oGmZT2MYtNaHPtpvQOud1WS_3rp57P1xajk_tk2k3DxqCcH7VNdpT__qfC47Xn-YDcc7CUji3BQ3LDVI_IrU_u4v0x-fPh_eQrbasfLYLTgh6fntK3FE_9a6ovDMVwXQrDqQxtFhTDbgF0mkULrcvFslnU3-FXVdC6zfDgB4nWUuyAM_StW3BboPgUY0rAKiie6tMNHJ-Q2cm7L8cT3z3k4OexlA1YoghzgG4mFpqbRPE8jKTSynCmIx7GoRJaBUkY6iQvGTMyM9yEoFxZkQgZZvwpGVUwg-eEJqVUeZ4EmKMUFQmsNLLgBdYbDYwCLOmRw-7jprmrco6PbczT1W07VylIOEURpwyI93vipS3usZnsFWpJajNTe5eQjsHdAT5UTHrk9YoCnQJwy7XLbYAxY3mtAeXugBKMOR807w00sR8WAC1EUjH071Qzdd6mTgHUxhIruXGP7PzfrAT8PeIQj9C-FRljfN1KF4AE9sGMx8EVJFjnKILdhEeeWZO4HBzjwD6CzgedjVxy3yjQg96ArhL8i2vS7ZBte9SPcai7ZNRctOYlYMUm23Me4i9zJmco
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IGHV+unmutated+CLL+B+cells+are+more+prone+to+spontaneous+apoptosis+and+subject+to+environmental+prosurvival+signals+than+mutated+CLL+B+cells&rft.jtitle=Leukemia&rft.au=Coscia%2C+M&rft.au=Griggio%2C+V&rft.au=Vitale%2C+C&rft.au=Boccadoro%2C+M&rft.date=2011-05-01&rft.pub=Nature+Publishing+Group&rft.issn=0887-6924&rft.volume=25&rft.issue=5&rft.spage=828&rft_id=info:doi/10.1038%2Fleu.2011.12&rft.externalDBID=n%2Fa&rft.externalDocID=A257125817
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-6924&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-6924&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-6924&client=summon